Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 5 hours ago
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 June 2026
about 6 hours ago
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 June...
Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPChFeLV, feline calicivirosis, feline rhinotracheitis, feline panleucopenia, feline chlamydiosis (live) and feline leukemia (RNA replicon particle) vaccine, Status: Opinion
about 6 hours ago
Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPChFeLV, feline calicivirosis...
Veterinary medicines European public assessment report (EPAR): Scovella, velagliflozin, Status: Opinion
about 6 hours ago
Veterinary medicines European public assessment report (EPAR): Scovella, velagliflozin, Status: Opinion
Veterinary medicines European public assessment report (EPAR): Nobivac NXT FeLV, feline leukemia (RNA particle) vaccine, Status: Opinion
about 6 hours ago
Veterinary medicines European public assessment report (EPAR): Nobivac NXT FeLV, feline leukemia...
Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPFeLV, feline calicivirosis, feline rhinotracheitis, feline panleucopenia (live) and feline leukemia (RNA replicon particle) vaccine, Status: Opinion
about 6 hours ago
Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPFeLV, feline calicivirosis...
EMA workshop on the challenges in drug development, regulation and clinical practice in immune thrombocytopenia, Online, from 30 June 2026, 14:00 (CEST) to 30 June 2026, 18:00 (CEST)
about 7 hours ago
EMA workshop on the challenges in drug development, regulation and clinical practice...
Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, efgartigimod alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: P/0298/2024
about 10 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, efgartigimod alfa, decision type...
Opinion/decision on a Paediatric investigation plan (PIP): Lupkynis, voclosporin, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0152/2019
about 10 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Lupkynis, voclosporin, decision type: PM...
Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Date of authorisation: 23/03/2018, Revision: 11, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Date of...